Paratek Pharmaceuticals, Inc. (PRTK) Financial Statements (2024 and earlier)
Company Profile
| Business Address |
75 PARK PLAZA BOSTON, MA 02116 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)Annual | Quarterly
| 6/30/2023 Q2 | 3/31/2023 Q1 | 12/31/2022 Q4 | 9/30/2022 Q3 | 6/30/2022 Q2 | 3/31/2022 Q1 | 12/31/2021 Q4 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments, including: | 45,000 | 34,200 | 57,000 | 69,400 | 79,100 | 95,500 | |||
| Cash and cash equivalents | 45,026 | 34,248 | 27,087 | 39,505 | 49,033 | 80,367 | |||
| Short-term investments | 29,922 | 29,886 | 30,020 | 15,107 | |||||
| Other undisclosed cash, cash equivalents, and short-term investments | (26) | (48) | (9) | 9 | 47 | 26 | |||
| Restricted cash and investments | 125 | 125 | 125 | 250 | 125 | ||||
| Receivables | 37,166 | 78,038 | 32,739 | 31,818 | 28,259 | 33,117 | |||
| Inventory, net of allowances, customer advances and progress billings | 13,989 | 16,565 | 20,750 | 13,083 | 12,732 | 11,020 | |||
| Inventory | 13,989 | 16,565 | 20,750 | 13,083 | 12,732 | 11,020 | |||
| Other undisclosed current assets | 14,734 | 7,914 | 10,727 | 13,467 | 12,941 | 12,338 | |||
| Total current assets: | 111,014 | 136,842 | 121,341 | 127,768 | 133,282 | 152,100 | |||
| Noncurrent Assets | |||||||||
| Inventory, Noncurrent | 35,590 | 31,314 | 33,117 | 32,662 | 32,955 | 27,767 | |||
| Operating lease, right-of-use asset | 1,639 | 1,782 | 1,128 | 1,352 | 1,536 | 1,757 | |||
| Property, plant and equipment | 601 | 616 | 663 | 712 | 762 | 794 | |||
| Intangible assets, net (including goodwill) | 829 | 829 | 829 | 829 | 829 | 829 | |||
| Goodwill | 829 | 829 | 829 | 829 | 829 | 829 | |||
| Restricted cash and investments | 125 | 125 | 125 | ||||||
| Other noncurrent assets | 1,155 | 1,155 | 243 | 247 | 668 | 497 | |||
| Total noncurrent assets: | 39,814 | 35,696 | 35,980 | 35,927 | 36,875 | 31,769 | |||
| TOTAL ASSETS: | 150,828 | 172,538 | 157,321 | 163,695 | 170,157 | 183,869 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 31,951 | 36,518 | 36,627 | 27,918 | 26,830 | 28,840 | |||
| Accounts payable | 5,318 | 5,308 | 8,107 | 2,257 | 4,697 | 5,394 | |||
| Accrued liabilities | 26,633 | 31,210 | 28,520 | 25,661 | 22,133 | 23,446 | |||
| Debt | |||||||||
| Other liabilities | 794 | 870 | 2,349 | 2,182 | 2,007 | 2,457 | |||
| Total current liabilities: | 32,745 | 37,388 | 38,976 | 30,100 | 28,837 | 31,297 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 257,695 | 256,946 | 259,103 | 258,007 | 257,012 | 255,736 | |||
| Long-term debt, excluding current maturities | 257,695 | 256,946 | 258,482 | 257,153 | 255,949 | 254,428 | |||
| Liabilities, other than long-term debt | 49,426 | 49,246 | 25,394 | 24,955 | 24,610 | 24,623 | |||
| Accounts payable and accrued liabilities | 45,636 | 45,325 | 22,874 | 22,339 | 21,893 | 21,846 | |||
| Other liabilities | 2,415 | 2,453 | 2,520 | 2,616 | 2,717 | 2,777 | |||
| Operating lease, liability | 1,375 | 1,468 | 621 | 854 | 1,063 | 1,308 | |||
| Total noncurrent liabilities: | 307,121 | 306,192 | 284,497 | 282,962 | 281,622 | 280,359 | |||
| Total liabilities: | 339,866 | 343,580 | 323,473 | 313,062 | 310,459 | 311,656 | |||
| Equity | |||||||||
| Equity, attributable to parent | (189,038) | (171,042) | (166,152) | (149,367) | (140,302) | (127,787) | |||
| Common stock | 57 | 56 | 55 | 55 | 53 | 52 | |||
| Additional paid in capital | 761,497 | 759,351 | 757,202 | 753,223 | 744,618 | 739,053 | |||
| Accumulated other comprehensive loss | (117) | (233) | (180) | (9) | |||||
| Accumulated deficit | (950,592) | (930,449) | (923,292) | (902,412) | (884,793) | (866,883) | |||
| Total equity: | (189,038) | (171,042) | (166,152) | (149,367) | (140,302) | (127,787) | |||
| TOTAL LIABILITIES AND EQUITY: | 150,828 | 172,538 | 157,321 | 163,695 | 170,157 | 183,869 | |||
Income Statement (P&L) ($ in thousands)Annual | Quarterly
| 6/30/2023 Q2 | 3/31/2023 Q1 | 12/31/2022 Q4 | 9/30/2022 Q3 | 6/30/2022 Q2 | 3/31/2022 Q1 | 12/31/2021 Q4 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 31,236 | 75,557 | 30,213 | 29,637 | 24,861 | 31,797 | ||
| Cost of revenue | (6,244) | (10,312) | (4,372) | (4,878) | (3,494) | (4,718) | ||
| Gross profit: | 24,992 | 65,245 | 25,841 | 24,759 | 21,367 | 27,079 | ||
| Operating expenses | (40,797) | (68,082) | (42,332) | (37,927) | (35,080) | (54,360) | ||
| Operating loss: | (15,805) | (2,837) | (16,491) | (13,168) | (13,713) | (27,281) | ||
| Nonoperating income | 199 | 295 | 147 | 95 | 282 | 17 | ||
| Investment income, nonoperating | 221 | 327 | 186 | 133 | 107 | 5 | ||
| Other nonoperating income (expense) | (22) | (32) | (39) | (38) | 175 | 12 | ||
| Interest and debt expense | (4,476) | (4,558) | (4,536) | (4,546) | (4,479) | (4,389) | ||
| Loss from continuing operations before income taxes: | (20,082) | (7,100) | (20,880) | (17,619) | (17,910) | (31,653) | ||
| Income tax expense | (61) | |||||||
| Other undisclosed loss from continuing operations | (57) | (600) | ||||||
| Loss from continuing operations: | (20,143) | (7,157) | (20,880) | (17,619) | (17,910) | (32,253) | ||
| Loss before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | (20,880) | (17,619) | (17,910) | (32,253) | |
| Net loss available to common stockholders, diluted: | (20,143) | (7,157) | (20,880) | (17,619) | (17,910) | (32,253) | ||
Comprehensive Income ($ in thousands)Annual | Quarterly
| 6/30/2023 Q2 | 3/31/2023 Q1 | 12/31/2022 Q4 | 9/30/2022 Q3 | 6/30/2022 Q2 | 3/31/2022 Q1 | 12/31/2021 Q4 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (20,143) | (7,157) | (20,880) | (17,619) | (17,910) | (32,253) | ||
| Other undisclosed comprehensive income (loss) | 9 | (13) | ||||||
| Comprehensive loss: | (20,143) | (7,148) | (20,880) | (17,619) | (17,910) | (32,266) | ||
| Other undisclosed comprehensive income (loss), net of tax, attributable to parent | 108 | 116 | (53) | (171) | 4 | |||
| Comprehensive loss, net of tax, attributable to parent: | (20,143) | (7,040) | (20,764) | (17,672) | (18,081) | (32,262) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.